Debate Over Autism Treatments and FDA Approvals
The Trump administration approved leucovorin, a vitamin B derivative, as a treatment for autism based on limited evidence, surprising experts and the drug's original proposer, Dr. Richard Frye, amid ongoing debates about its efficacy and the need for further research.